Helix BioPharma Corp. announced Frank Michalargias has notified the board of directors of the company of his intention to resign from the position of chief financial officer, effective no later than May 15, 2022. Mr. Michalargias will be departing the Company to pursue a new employment opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 CAD | +22.73% | +28.57% | +28.57% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.57% | 48.12M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. Announces Resignation of Frank Michalargias as Chief Financial Officer